Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Frontiers in Public Health|December 19, 2025
The Ugandan youth public health ambassador program: a community-based public health initiativeHeather Wipfli, Abigail Kim, Cecilia Alonyo, et al.The Journal of Behavioral Health Services & Research|October 9, 2014
Transitioning Youth into Adult Mental Health and Addiction Services: An Outcomes Evaluation of the Youth Transition ProjectM Cappelli, S Davidson, J Racek, et al.Veterinary Parasitology|February 27, 2001
Immunoconversion against Sarcocystis neurona in normal and dexamethasone-treated horses challenged with S. neurona sporocystsT J Cutler, R J MacKay, P E Ginn, et al.Journal of Cellular Biochemistry|April 22, 2003
Transcriptional profiling of human osteoblast differentiationJ Billiard, R A Moran, M Z Whitley, et al.The West Indian Medical Journal|May 6, 2010
Results of an exercise to estimate the costs of interpersonal violence in JamaicaE Ward, T McCartney, D W Brown, et al.Oncotarget|February 1, 2018
Tumor exome sequencing and copy number alterations reveal potential predictors of intrinsic resistance to multi-targeted tyrosine kinase inhibitorsNancy K Gillis, Daniel M Rotroff, Tania E Mesa, et al.The Journal of Cell Biology|May 12, 2020
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cellsHaohui Duan, Sarah Mansour, Rachel Reed, et al.The Oncologist|February 10, 2017
Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee ExperienceTodd C Knepper, Gillian C Bell, J Kevin Hicks, et al.Cancer Research|August 1, 1985
A nontoxic system for 41.8 degrees C whole-body hyperthermia: results of a Phase I study using a radiant heat deviceH I Robins, W H Dennis, A J Neville, et al.Leukemia|December 14, 2011
Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phaseF J Giles, H M Kantarjian, P D le Coutre, et al.Pageof 8